Dyslipidemia which has been closely linked to the pathophysiology of cardiovascular disease is a key independent risk factor for cardiovascular disease. Highly active antiretroviral (HAART) has dramatically reduced AIDS morbidity and mortality; however the studies have shown that HAART is associated with increase in incidence of dyslipidemia. So it is very necessary to screen every individual seropositive with HIV who is going to start HAART to minimize the comorbid risk of cardiovascular disease in AIDS and ensure proper planning of health actions for both primary and secondary prevention of cardiovascular disease.